Worth reading
64In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
4
植物由来成分（エキス）の種類Wording
Conditional
How definitive the wording is.Announced details
Glycoxidative Damage Inhibitor
Applicable field (uses covered by this announcement)
毛髪ダメージの分析・解明、新規ヘアケア製品の開発、美容業界
What the company reported numerically
Quantitative Effects
ブリーチ処理と紫外線照射処理を施した毛髪でAGEs様物質が多量に生成。4種のエキスで高い抑制効果を確認。エキス無し100%、ザクロエキス71%、ムクロジエキス55%、アンマロクエキス54%、ターミナリアベレリカエキス30%（AGEs様物質の増加率）
Relationship between the counterparty and the company
COTA CO.,LTD.4923
Relationship with the Company
Joint Research
Counterparty同志社大学生命医科学部 八木雅之客員教授
同志社大学生命医科学部の客員教授。糖化研究の専門家。
Impact on Business Performance
2026年3月期の業績に与える影響はございません。
The company does not address Contract Value / Offering price.
Source (materials cited by the company)
第35回国際化粧品技術者会連盟カンヌ大会2025
| Item | Details |
|---|---|
| Names of Products / Services Covered | Glycoxidative Damage Inhibitor |
| Counterparty | 同志社大学生命医科学部 八木雅之客員教授 |
| Counterparty overview | 同志社大学生命医科学部の客員教授。糖化研究の専門家。 |
| Relationship with the Company | Joint Research |
| Applicable area | 毛髪ダメージの分析・解明、新規ヘアケア製品の開発、美容業界 |
| Quantitative Effects | ブリーチ処理と紫外線照射処理を施した毛髪でAGEs様物質が多量に生成。4種のエキスで高い抑制効果を確認。エキス無し100%、ザクロエキス71%、ムクロジエキス55%、アンマロクエキス54%、ターミナリアベレリカエキス30%（AGEs様物質の増加率） |
| Impact on Business Performance | 2026年3月期の業績に与える影響はございません。 |
| Source | 第35回国際化粧品技術者会連盟カンヌ大会2025 |
Items this document does not state (10)
Contract ValueOffering priceContract DateLaunch dateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleUsage history
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.毛髪ダメージを定量化・分析し、消費者が求める毛髪のツヤや感触等に応える製品開発につなげるため。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.